Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Mesa Laboratories, Inc.

Market Cap 593M 515M 474M 445M 831M 56.79B 848M 5.66B 2.19B 27.37B 2.23B 2.18B 95.18B P/E Ratio 2027 *
78.9x
P/E Ratio 2028 * 50.1x
Enterprise Value 593M 515M 474M 445M 831M 56.79B 848M 5.66B 2.19B 27.37B 2.23B 2.18B 95.18B EV / Sales 2027 *
2.29x
EV / Sales 2028 * 2.18x
Free-Float
94.45%
Yield 2027 *
0.6%
Yield 2028 * 0.6%
1 day+0.61%
1 week+3.60%
Current month+5.50%
1 month+3.80%
3 months+38.32%
6 months+38.40%
Current year+37.11%
1 week 103.94
Extreme 103.9425
113.99
1 month 81.3
Extreme 81.3
113.99
Current year 71.06
Extreme 71.065
113.99
1 year 55.45
Extreme 55.45
113.99
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 56 12/04/2026
Director of Finance/CFO 57 29/10/2012
Corporate Officer/Principal - 01/05/2020
Director TitleAgeSince
Chairman 73 01/09/2017
Director/Board Member 57 04/03/2019
Director/Board Member 57 11/05/2020
Date Insider Type Main position Quantity % Market Cap.
04-14Free

Chief Executive Officer

35,236 0.6378%
03-31Issuer sale

Chief Executive Officer

8,211 0.1486%
03-10Buy

Director

1,301 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+3.60%+7.75%-21.01% 593M
-2.05%-3.49%-35.58%-13.32% 156B
-0.34%-1.93%-9.49%-4.97% 103B
-0.28%+1.96%-4.95%+56.39% 54.77B
+3.00%-0.04%+54.23%+54.37% 53.52B
-1.28%-3.74%-16.60%-41.96% 40.6B
-2.96%+7.59% - - 31.4B
-1.02%+2.25%-10.08%-41.30% 29.04B
-0.61%+4.55%+46.20%-8.00% 23.34B
-2.85%-3.36%-17.02%-0.74% 20.81B
Average -0.76%+1.73%+1.61%-2.28% 51.33B
Weighted average by Cap. -0.88%+0.39%-8.59%+0.60%

Financials

2027 *2028 *
Net sales 259M 225M 207M 194M 363M 24.82B 371M 2.47B 957M 11.96B 973M 952M 41.59B 272M 236M 218M 204M 381M 26.06B 389M 2.6B 1.01B 12.56B 1.02B 1B 43.68B
Net income 7.57M 6.57M 6.05M 5.67M 10.6M 725M 10.82M 72.2M 27.95M 349M 28.41M 27.79M 1.21B 12.13M 10.53M 9.71M 9.09M 16.99M 1.16B 17.35M 116M 44.83M 560M 45.55M 44.57M 1.95B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
12/06/26 107.63 $ +0.26% 267,130
11/06/26 107.35 $ +0.12% 239,530
10/06/26 107.22 $ -1.66% 273,164
09/06/26 109.03 $ +0.53% 362,700
08/06/26 108.46 $ +4.40% 181,463
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
107.35USD
Average target price
112.00USD
Spread / Average Target
+4.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!